Novozymes A/S
OTC:NVZMF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
53.6
75.91
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
88.3B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
79.3B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
10.6T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
267B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
29.2B CHF |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.6T INR |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
25.3B USD |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| US |
|
Albemarle Corp
NYSE:ALB
|
21.4B USD |
Loading...
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
17.3B EUR |
Loading...
|
Market Distribution
| Min | -5 981.6% |
| 30th Percentile | 1.3% |
| Median | 7.5% |
| 70th Percentile | 16.3% |
| Max | 423.3% |
Other Profitability Ratios
Novozymes A/S
Glance View
Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Novozymes A/S is 24.9%, which is below its 3-year median of 25.5%.
Over the last 3 years, Novozymes A/S’s Operating Margin has decreased from 25.8% to 24.9%. During this period, it reached a low of 24.9% on Jan 1, 2024 and a high of 27.5% on Sep 30, 2021.